[Clinical analysis of left atrial appendage occlusion for stroke prevention in elderly patients with atrial

W L Dai1, R Yang1, P F Guo1

  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing 100029, China.

Zhonghua Nei Ke Za Zhi
|August 27, 2021
PubMed

Insights

Left atrial appendage occlusion (LAAO) is safe and effective for preventing stroke in elderly patients with atrial fibrillation (AF). This procedure shows comparable perioperative safety and long-term stroke risk reduction in older adults compared to younger patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Geriatric Medicine

Background:

  • Atrial fibrillation (AF) significantly increases stroke risk, particularly in elderly patients.
  • Left atrial appendage occlusion (LAAO) is an alternative to anticoagulation for stroke prevention in AF.
  • Limited data exists on LAAO efficacy and safety specifically in patients over 75 years old.

Purpose of the Study:

  • To evaluate the efficacy and safety of LAAO in patients with AF aged over 75 years.
  • To compare perioperative complications and long-term outcomes (ischemic stroke, major bleeding) between elderly ( >75 years) and younger (≤75 years) AF patients undergoing LAAO.

Main Methods:

  • Retrospective analysis of 82 AF patients who underwent successful LAAO.
  • Patients were divided into an elderly group (>75 years) and a younger group (≤75 years).
  • Perioperative risks and follow-up events including ischemic stroke and major bleeding were analyzed.

Main Results:

  • No significant differences in perioperative ischemic stroke or major bleeding between groups.
  • No deaths or pericardial tamponade occurred in either group.
  • During follow-up (25.9±15.9 months), the elderly group had a stroke rate of 3.6/100 person-years and a major bleeding rate of 2.5/100 person-years; the younger group had rates of 4.9/100 person-years and 0/100 person-years, respectively. The elderly group showed a more profound relative risk reduction for stroke (32.0% vs. 25.0%).

Conclusions:

  • LAAO demonstrates comparable safety and efficacy in elderly AF patients compared to younger counterparts.
  • LAAO is a potentially suitable option for stroke prevention in elderly AF patients.
  • While stroke risk reduction was greater in the elderly, major bleeding risk was higher, warranting careful consideration.